Liposome Drug Delivery Market Trends | Global Forecast to 2027

    Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Others); Technology ( Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome (LTSL)); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy)

    Publication Month: Apr 2020 | Report Code: TIPRE00010407 | No. of Pages: 177 | Category: Pharmaceuticals | Status: Published

    The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.

    Liposomes, a novel drug delivery system (NDDS), are bilayer vesicular structures used in delivering drugs or genetic material into a cell. The aim of NDDS is to deliver the drug at a rate directed by the needs of the body during the period of treatment. Due to the growing number of COVID-19 patients, especially in the US and the European countries, research institutes are pressurized to accelerate their R&D activities to develop drugs and vaccines for the treatment. Thus, companies in the liposome drug delivery market are capitalizing on this opportunity to increase their research in nanomaterials, such as nanospheres, liposomes, and nanoparticles that are active antiviral agents. Liposome drug delivery is being leveraged with increased in vivo and in vitro drug activities for routine clinical practices.

    Lucrative Regions for Liposome Drug Delivery Market


    Lucrative Regions for Liposome Drug Delivery Market

    Get more information on this report :



    Market Insights

    Increasing Prevalence of Chronic Diseases

    Over the past few decades, R&D activities in liposomal drug delivery systems have rapidly increased across the world due to increasing prevalence of chronic disease. Drug delivery is the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Liposomal drug delivery offers various advantages, such as improved pharmacokinetics and pharmacodynamics, enhanced therapeutic efficacy, and decreased toxicity, thereby making these delivery systems ideal for patients suffering from various chronic conditions. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases.

    Cancer is one of the leading causes of death among population worldwide. The American Cancer Society (ACS) estimated that ~1,735,350 new cancer cases were diagnosed in 2018. Targeted drug delivery system (TDDS) delivers the drug in a controlled manner at a preselected biosite. Nanotechnology-based delivery systems are making a significant impact on cancer treatment and the polymers play a key role in the development of nanoparticulate carriers for cancer therapy. A few major technological advantages involved in the nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved bio-distribution, increased circulation time of the drug, controlled and sustained release of the drug, versatility of route of administration, increased intercellular concentration of drug, and many more. The liposomal carriers utilized in nanotechnology drug delivery systems are likely to experience rapid adoption, which, in turn, is propel the market growth.

    Product -Based Market Insights

    The liposome drug delivery market, based on product, is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. In 2019, the liposomal doxorubicin accounted for the largest share by product owing to the high efficacy of the drug exhibited in the treatment of cancer. Moreover, the liposomal doxorubicin is beneficial over its traditional counterpart in terms of toxicity and targeted drug delivery. The drug also exhibits significant recovery among patients suffering with HIV-related Kaposi’s sarcoma and multiple myeloma.

    Global Liposome Drug Delivery Market, by Product– 2019 and 2027

    Global Liposome Drug Delivery Market, by Product– 2019 and 2027

    Get more information on this report :



    Technology-Based Market Insights

    Based on technology, the liposome drug delivery market is segmented into stealth liposome technology, non-PEGylated liposome technology, DepoFoam liposome technology. The stealth liposome technology segment held the largest share of the market in 2019 and is likely to continue to register the highest CAGR in the market during the forecast period.

    Application-Based Market Insights

    Based on technology, the liposome drug delivery market is segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy. The cancer therapy segment held the largest share of the market in 2019 and is likely to continue to register the highest CAGR in the market during the forecast period.

    Strategic Insights

    Partnerships, agreements, and acquisitions are the most commonly adopted strategies by companies to expand their footprints worldwide and meet the growing demand. The market players most commonly adopt these strategies to expand their geographic presence and product portfolio.

    For instance, in April 2019, Ipsen Pharma completed its acquisition of global oncology assets from Merrimack Pharmaceuticals, Cambridge that focuses on ONIVYDE (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.

    Global Liposome Drug Delivery Market – By Product

    • Liposomal Doxorubicin
    • Liposomal Paclitaxel
    • Liposomal Amphotericin B
    • Others

    Global Liposome Drug Delivery Market – By Technology

    • Stealth Liposome Technology
    • Non-PEGylated Liposome Technology
    • DepoFoam Liposome Technology
    • Lysolipid Thermally Sensitive Liposome (LTSL) Technology

    Global Liposome Drug Delivery Market – By Application

    • Fungal Diseases
    • Cancer Therapy
    • Pain Management
    • Viral Vaccines
    • Photodynamic Therapy

    Liposome Drug Delivery Market – By Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
    • Asia Pacific

      • China
      • India
      • South Korea
      • Japan
      • Australia
    • Middle East and Africa

      • South Africa
      • Saudi Arabia
      • UAE
    • South and Central America

      • Brazil
      • Argentina

    Company Profiles

    • Takeda Pharmaceutical Company Limited
    • Novartis AG
    • Luye Pharma Group
    • Ipsen Pharma
    • CELSION, Inc.
    • Gilead Sciences, Inc.
    • Astellas Pharma, Inc.
    • Johnson & Johnson Services, Inc.
    • Acrotech Biopharma, Inc.

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Liposome Drug Delivery Market – By Product

    1.3.2 Global Liposome Drug Delivery Market – By Technology

    1.3.3 Global Liposome Drug Delivery Market – By Application

    1.3.4 Global Liposome Drug Delivery Market – By Geography

    2. Liposome Drug Delivery Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Liposome Drug Delivery – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 Europe– PEST Analysis

    4.2.2 Asia Pacific– PEST Analysis

    4.2.3 Middle East & Africa

    4.2.4 South and Central America

    4.3 Expert Opinion

    5. Global Liposome Drug Delivery Market – Industry Dynamics

    5.1 Market Drivers

    5.1.1 Rising prevalence of Chronic Diseases

    5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices

    5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies

    5.2 Market Restraints

    5.2.1 High Cost Involved in Development of Drug Delivery Systems

    5.3 Market Opportunities

    5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs

    5.4 Future Trends

    5.4.1 Increasing Popularity of Liposomes in Drug Delivery

    5.5 Impact Analysis

    6. Liposome Drug Delivery Market – Global Analysis

    6.1 Global Liposome Drug Delivery Market Revenue Forecast And Analysis

    6.2 Global Liposome Drug Delivery Market, By Geography - Forecast And Analysis

    6.3 Market Positioning of Key Players

    7. Liposome Drug Delivery Market Analysis – By Product

    7.1 Overview

    7.2 Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)

    7.3 Liposomal Doxorubicin

    7.3.1 Overview

    7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    7.4 Liposomal Paclitaxel

    7.4.1 Overview

    7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    7.5 Liposomal Amphotericin B

    7.5.1 Overview

    7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    7.6 Others

    7.6.1 Overview

    7.6.2 Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    8. Liposome Drug Delivery Market – By Technology

    8.1 Overview

    8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

    8.3 Stealth Liposome Technology

    8.3.1 Overview

    8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    8.4 Non-PEGylated Liposome Technology

    8.4.1 Overview

    8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    8.5 DepoFoam Liposome Technology

    8.5.1 Overview

    8.5.2 DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology

    8.6.1 Overview

    8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    9. Liposome Drug Delivery Market – By Application

    9.1 Overview

    9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

    9.3 Fungal Diseases

    9.3.1 Overview

    9.3.2 Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    9.4 Cancer Therapy

    9.4.1 Overview

    9.4.2 Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    9.5 Pain Management

    9.5.1 Overview

    9.5.2 Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    9.6 Viral Vaccine

    9.6.1 Overview

    9.6.2 Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    9.7 Photodynamic Therapy

    9.7.1 Overview

    9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    10. Liposome Drug Delivery Market – Geographic Analysis

    10.1 North America: Liposome Drug Delivery Market

    10.1.1 Overview

    10.1.2 North America: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.1.3 North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.1.4 North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.1.5 North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    10.1.7 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.1 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.2 US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.1.7.3 US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.1.7.4 US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.8 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.1 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.2 Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.1.8.3 Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.1.8.4 Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.9 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.1.9.1 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.1.9.2 Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.1.9.4 Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.2 Europe: Liposome Drug Delivery Market

    10.2.1 Overview

    10.2.2 Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)

    10.2.3 Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.4 Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.5 Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.2.6 Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    10.2.7 Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.7.1 Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.7.2 Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.7.3 Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.7.4 Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.2.8 UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.8.1 UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.8.2 United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.8.3 United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.8.4 United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.2.9 France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.9.1 France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.9.2 France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.9.3 France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.9.4 France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.2.10 Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.10.1 Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.10.2 Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.10.3 Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.10.4 Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.2.11 Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.11.1 Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.2.11.2 Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.11.3 Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.11.4 Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.3 Asia Pacific: Liposome Drug Delivery Market

    10.3.1 Overview

    10.3.2 Asia Pacific: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)

    10.3.3 Asia Pacific Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.3.4 Asia Pacific Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.3.5 Asia Pacific Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.3.6 Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    10.3.7 China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.7.1 China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.7.2 China Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.3.7.3 China Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.3.7.4 China Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.3.8 Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.8.1 Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.8.2 Japan Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.3.8.3 Japan Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.3.8.4 Japan Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.3.9 India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.9.1 India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.9.2 India Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.3.9.3 India Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.3.9.4 India Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.3.10 South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.1 South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.2 South Korea Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.3.10.3 South Korea Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.3.10.4 South Korea Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.3.11 Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.11.1 Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.3.11.2 Australia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.3.11.3 Australia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.3.11.4 Australia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.4 Middle East & Africa: Liposome Drug Delivery Market

    10.4.1 Overview

    10.4.2 Middle East & Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

    10.4.3 Middle East & Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.4.4 Middle East & Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.5 Middle East & Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.4.6 Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)

    10.4.7 Saudi Arabia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.4.7.1 Saudi Arabia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.4.7.2 Saudi Arabia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.4.7.3 Saudi Arabia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.7.4 Saudi Arabia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.4.8 UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.4.8.1 UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.4.8.2 UAE Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.4.8.3 UAE Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.8.4 UAE Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.4.9 South Africa: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.4.9.1 South Africa: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.4.9.2 South Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.4.9.3 South Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.9.4 South Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.5 South and Central America: Liposome Drug Delivery Market

    10.5.1 Overview

    10.5.2 South and Central America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)

    10.5.3 South and Central America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.5.4 South and Central America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.5.5 South and Central America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.5.6 South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    10.5.7 Brazil: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.5.7.1 Brazil: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.5.7.2 Brazil Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.5.7.3 Brazil Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.5.7.4 Brazil Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.5.8 Argentina: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.5.8.1 Argentina: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    10.5.8.2 Argentina Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.5.8.3 Argentina Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.5.8.4 Argentina Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    11. Impact Of COVID-19 Pandemic On Global Liposome Drug Delivery Market

    11.1 North America: Impact Assessment of COVID-19 Pandemic

    11.2 Europe: Impact assessment of COVID-19 Pandemic

    11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

    12. Liposome Drug Delivery Market –Industry Landscape

    12.1 Overview

    12.2 Organic Growth Strategies

    12.2.1 Overview

    12.3 Inorganic Growth Strategies

    12.3.1 Overview

    13. Liposome Drug Delivery Market –Company Profiles

    13.1 Takeda Pharmaceutical Company Limited

    13.1.1 Key Facts

    13.1.2 Business Description

    13.1.3 Products and Services

    13.1.4 Financial Overview

    13.1.5 SWOT Analysis

    13.1.6 Key Developments

    13.2 Novartis AG

    13.2.1 Key Facts

    13.2.2 Business Description

    13.2.3 Products and Services

    13.2.4 Financial Overview

    13.2.5 SWOT Analysis

    13.2.6 Key Developments

    13.3 Luye Pharma Group

    13.3.1 Key Facts

    13.3.2 Business Description

    13.3.3 Products and Services

    13.3.4 Financial Overview

    13.3.5 SWOT Analysis

    13.3.6 Key Developments

    13.4 Johnson & Johnson Services, Inc.

    13.4.1 Key Facts

    13.4.2 Business Description

    13.4.3 Products and Services

    13.4.4 Financial Overview

    13.4.5 SWOT Analysis

    13.4.6 Key Developments

    13.5 Ipsen Pharma

    13.5.1 Key Facts

    13.5.2 Business Description

    13.5.3 Products and Services

    13.5.4 Financial Overview

    13.5.5 SWOT Analysis

    13.5.6 Key Developments

    13.6 Gilead Sciences, Inc.

    13.6.1 Key Facts

    13.6.2 Business Description

    13.6.3 Products and Services

    13.6.4 Financial Overview

    13.6.5 SWOT Analysis

    13.6.6 Key Developments

    13.7 Celsion, Inc.

    13.7.1 Key Facts

    13.7.2 Business Description

    13.7.3 Products and Services

    13.7.4 Financial Overview

    13.7.5 SWOT Analysis

    13.7.6 Key Developments

    13.8 Astellas Pharma Inc.

    13.8.1 Key Facts

    13.8.2 Business Description

    13.8.3 Products and Services

    13.8.4 Financial Overview

    13.8.5 SWOT Analysis

    13.8.6 Key Developments

    13.9 Acrotech Biopharma LLC

    13.9.1 Key Facts

    13.9.2 Business Description

    13.9.3 Products and Services

    13.9.4 Financial Overview

    13.9.5 SWOT Analysis

    13.9.6 Key Developments

    13.10 Pacira BioSciences, Inc.

    13.10.1 Key Facts

    13.10.2 Business Description

    13.10.3 Products and Services

    13.10.4 Financial Overview

    13.10.5 SWOT Analysis

    13.10.6 Key Developments

    14. Appendix

    14.1 About The Insight Partners

    14.2 Glossary of Terms

    LIST OF TABLES

    Table 1. R&D Investments by major pharmaceutical companies

    Table 2. North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 3. North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 4. North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 5. US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 6. US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 7. US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 8. Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 9. Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 10. Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 11. Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 12. Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 13. Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 14. Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 15. Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 16. Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 17. Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 18. Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 19. Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 20. United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 21. United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 22. United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 23. France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 24. France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 25. France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 26. Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 27. Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 28. Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 29. Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 30. Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 31. Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 32. Asia Pacific Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 33. Asia Pacific Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 34. Asia Pacific Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 35. China Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 36. China Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 37. China Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 38. Japan Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 39. Japan Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 40. Japan Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 41. India Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 42. India Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 43. India Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 44. South Korea Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 45. South Korea Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 46. South Korea Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 47. Australia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 48. Australia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 49. Australia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 50. Middle East & Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 51. Middle East & Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 52. Middle East & Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 53. Saudi Arabia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 54. Saudi Arabia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 55. Saudi Arabia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 56. UAE Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 57. UAE Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 58. UAE Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 59. South Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 60. South Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 61. South Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 62. South and Central America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 63. South and Central America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 64. South and Central America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 65. Brazil Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 66. Brazil Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 67. Brazil Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 68. Argentina Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 69. Argentina Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 70. Argentina Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 71. Recent Organic Growth Strategies in the Liposome Drug Delivery Market

    Table 72. Recent Inorganic Growth Strategies In The Liposome Drug Delivery Market

    Table 73. Glossary of Terms, Liposome Drug Delivery Market

    LIST OF FIGURES

    Figure 1. Liposome Drug Delivery Market Segmentation

    Figure 2. Liposome Drug Delivery Segmentation, By Region

    Figure 3. Global Liposome Drug Delivery Market Overview

    Figure 4. The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market

    Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

    Figure 6. Global Liposome Drug Delivery Market, By Geography (US$ Million)

    Figure 7. Global Liposome Drug Delivery Market, Industry Landscape

    Figure 8. Global Liposome Drug Delivery Market- Leading Country Markets (US$ Million)

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East & Africa PEST Analysis

    Figure 13. South and Central America PEST Analysis

    Figure 14. Global Liposome Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027

    Figure 15. Global Liposome Drug Delivery Market – By Geography Forecast and Analysis – 2019- 2027

    Figure 16. Market Positioning Of Key Players In Global Liposome Drug Delivery Market

    Figure 17. Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)

    Figure 18. Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 19. Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 20. Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 21. Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 22. Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

    Figure 23. Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 24. Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 25. DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 26. Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 27. Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

    Figure 28. Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 29. Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 30. Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 31. Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 32. Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 33. North America: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

    Figure 34. North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

    Figure 35. North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    Figure 36. US: Liposome Drug Delivery market – Revenue and Forecast to 2027 (USD Million)

    Figure 37. Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 38. Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 39. Europe: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

    Figure 40. Europe Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

    Figure 41. Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    Figure 42. Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 43. UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 44. France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 45. Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 46. Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 47. Asia Pacific: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

    Figure 48. Asia Pacific Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

    Figure 49. Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    Figure 50. China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 51. Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 52. India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 53. South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 54. Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 55. Middle East & Africa: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

    Figure 56. Middle East & Africa Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

    Figure 57. Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)

    Figure 58. Saudi Arabia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 59. UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 60. South Africa: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 61. South and Central America: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

    Figure 62. South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

    Figure 63. South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

    Figure 64. Brazil: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 65. Argentina: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

    Figure 66. Impact of COVID-19 Pandemic In North American Country Markets

    Figure 67. Impact of COVID-19 Pandemic In European Country Markets

    Figure 68. Impact of COVID-19 Pandemic In Asia Pacific Country Markets

    Figure 69. Impact Of COVID-19 Pandemic In Rest of the World Market

    The List of Companies - Liposome Drug Delivery Market

    1. Takeda Pharmaceutical Company Limited
    2. Novartis AG
    3. Luye Pharma Group
    4. Ipsen Pharma
    5. CELSION, Inc.
    6. Gilead Sciences, Inc.
    7. Astellas Pharma, Inc.
    8. Johnson & Johnson Services, Inc.
    9. Acrotech Biopharma, Inc.
    10. Pacira Biosciences, Inc.
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liposome drug delivery market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global liposome drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPRE00010407
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Pricing
    • $3000
    • $4550 $3640
    • $6550 $5240
    • $8550 $6840

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst